Stallmach, A <br/><br/>
An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.  [electronic resource] 

 -  Gut  Mar 2004 
 - 339-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0017-5749 
<br/><br/><label>Standard No.: </label>10.1136/gut.2003.020107  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Animals<br/>Apoptosis--drug effects<br/>Cell Division--drug effects<br/>Cells, Cultured<br/>Colitis--chemically induced<br/>Crohn Disease--immunology<br/>Disease Models, Animal<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Immunoglobulin G--metabolism<br/>Interferon-gamma--biosynthesis<br/>Interleukin-12--metabolism<br/>Interleukin-12 Subunit p40<br/>Leukocytes, Mononuclear--drug effects<br/>Male<br/>Mice<br/>Mice, Inbred BALB C<br/>Middle Aged<br/>Prospective Studies<br/>Protein Subunits--metabolism<br/>Receptors, Interleukin--metabolism<br/>Receptors, Interleukin-12<br/>Recombinant Fusion Proteins--metabolism<br/>Trinitrobenzenesulfonic Acid